Trikafta-Extending Its Success to Less Common Mutations

Lea Bentur; Mordechai Pollak

doi:10.3390/jpm12091528

Trikafta-Extending Its Success to Less Common Mutations

J Pers Med. 2022 Sep 19;12(9):1528. doi: 10.3390/jpm12091528.

Authors

Lea Bentur^{1

2}, Mordechai Pollak^{1

2}

Affiliations

¹ Pediatric Pulmonary Institute, Ruth Children's Hospital, Rambam Health Care Center, Haifa 31096, Israel.
² Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 32000, Israel.

Abstract

Cystic Fibrosis (a genetic recessive disease) is caused by a mutant cystic fibrosis transmembrane conductance regulator (CFTR) gene that causes an absence of, or impaired CFTR activity [...].

Publication types

Editorial

Grants and funding

This research received no external funding.